Clinical Development

With more than 40 years’ experience as a clinical research organization, NUVISAN offers the full range of solutions for clinical drug development, including first-in-human clinical trials and dose escalation studies for healthy subjects, special populations, and patients. We support our clients with clinical study protocols and establishing clinical development plans. We are familiar with regulatory requirements in Europe and can assist you with sample size calculations and planning the design elements and statistical evaluation of a clinical trial.
NUVISAN offers bioanalysis, immunology, and safety laboratories under one roof at our well-equipped phase-I units in Neu-Ulm for your FIH studies

Contact Us Go to our Main Page